Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02258685 · ClinicalTrials.gov registry record
Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 93
- Enrollment target
NCT02258685 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 93 participants.
The verdict
NCT02258685 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
Study Summary
This study plans to learn more about immune responses in intestinal (gut) tissue in people with human immunodeficiency virus (HIV) infection. This study will determine whether change in the composition of gut bacteria in HIV infected individuals is related to a high prevalence of chronic gut inflammation and metabolic disease. The investigators will also investigate immune-modulatory properties of specific bacteria that correlate with disease both by characterizing which functional genes are selected for in their genomes and by stimulating immune cells isolated from blood and gut tissue with bacterial isolates. This work will establish whether gain/loss of bacterial drivers/suppressors of information in the gut contributes to metabolic disease in HIV-infected individuals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02258685
The ClinicalTrials.gov registry entry for NCT02258685 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02258685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02258685 about?
NCT02258685 is a clinical study titled "Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.". This study plans to learn more about immune responses in intestinal (gut) tissue in people with human immunodeficiency virus (HIV) infection. This study will determine whether change in the composition of gut bacteria in HIV infected individuals is related to a high prevalence of chronic gut inflamm...
What is the current status of trial NCT02258685?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2014-11. Estimated completion is 2019-07.
Who is sponsoring clinical trial NCT02258685?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.